Related Experiment Videos
Pharmacologic modulation of acute uveitis with aminonicotinamide
G E Marak1, T W Sery, D Gregerson
1Center for Sight Georgetown II., Washington, D.C.
Ophthalmic Research
|January 1, 1990
Summary
The anti-inflammatory drug 6-aminonicotinamide effectively treated experimental uveitis by inhibiting the pentose phosphate pathway. This inhibition reduced superoxide radical production in inflammatory cells, suggesting a novel antiphlogistic mechanism.
Area of Science:
- Biochemistry
- Immunology
- Ophthalmology
Background:
- Acute inflammatory cells generate electrons for superoxide radical production via the pentose phosphate pathway.
- Uveitis is an inflammatory eye condition with significant morbidity.
Purpose of the Study:
- To investigate the anti-inflammatory effects of 6-aminonicotinamide in experimental uveitis.
- To explore the role of the pentose phosphate pathway in mediating inflammation.
Main Methods:
- Administration of 6-aminonicotinamide, a hexose monophosphate shunt inhibitor, in a model of experimental uveitis.
- Assessment of inflammatory markers and superoxide production.
Main Results:
- 6-aminonicotinamide demonstrated a significant anti-inflammatory effect in experimental uveitis.
- Inhibition of the hexose monophosphate shunt correlated with reduced superoxide production.
Conclusions:
- 6-aminonicotinamide possesses antiphlogistic properties relevant to uveitis treatment.
- Inhibition of superoxide production by the pentose phosphate pathway is a potential mechanism for the observed anti-inflammatory effects.